Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Science & Co

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Science & Co head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 100 · Grade C

Science & Co

Visit Science & Co Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 75 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Science & Co a bad call — it's best for readers considering a longer compounded treatment plan who will verify the total commitment and cancellation rules before relying on a promotional monthly equivalent. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
70
Supply Reliability
95
76
Transparency
90
82
Access Breadth
93
74
Clinical Oversight
92
76
Track Record
88
76
CoreAge RxBrief Score 94 · 75Science & Co

Price, coverage & the tracker

CoreAge RxScience & Co
Brief Score94/100 (A)75/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm annual-plan payment schedule

Promotional $49/mo equivalent on a 12-month plan; payment and renewal terms unknown.

Full price details

Billing unconfirmed; payment schedule unknown. Promotional $49/month equivalent on a 12-month compounded plan

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm annual-plan payment schedule

Promotional $89/mo equivalent on a 12-month plan; payment and renewal terms unknown.

Full price details

Billing unconfirmed; payment schedule unknown. Promotional $89/month equivalent on a 12-month compounded plan

CoverageUS only; restrictions by state, confirmed at intakeAll 50 states and D.C. advertised; confirm the selected prescription and pharmacy access
Brand-name accessNot confirmedNot confirmed
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Science & Co: The $49 semaglutide and $89 tirzepatide offers are monthly equivalents on twelve-month promotional plans. Confirm the full payment schedule and renewal price; these are not established month-to-month rates.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.